Emil Billback is the founder of BONESUPPORT. BONESUPPORT has raised $39M in total funding. Latest round: Post IPO. Based in Lund, Sweden.
Emil Billbäck was appointed CEO of BONESUPPORT, a Sweden-based orthobiologics company. In this role, he oversaw the company's receipt of FDA market authorization for Cerament G, the first bone graft with antibiotic elution approved for the US market. He was also elected as a director of Bonesupport Holding AB.
Full founder directory · Investor directory · Company funding database · Fundraising library